A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics.

from MobiHealthNews https://ift.tt/2Jk3b5i

Related Posts:

0 comments:

Post a Comment

Popular Posts